Ibogaine, a naturally occurring psychoactive substance derived from the root bark of the Tabernanthe iboga plant native to Central Africa, has …
Ibogaine, a naturally occurring psychoactive substance derived from the root bark of the Tabernanthe iboga plant native to Central Africa, has …
Toronto-based Psyence Biomedical Ltd (NASDAQ: PBM) just invested US$500,000 into the private South African drug developer PsyLabs. The capital injection follows Psyence taking an 11 per cent stake in the natural psychedelics company in September.
PsyLabs is federally licensed to produce psilocybin, psilocin, mescaline, DMT and ibogaine for international research partners at its facility in Cape Town. It has been in operation for four years. The extraction ...
Ibogaine, a psychoactive compound extracted from the African Tabernanthe iboga plant, has gained attention for its potential to disrupt addictive …
Arizona lawmakers asked to fund a new medical research center
Kyrsten Sinema appears before lawmakers from the Arizona House of Representatives stumping for appropriations for traumatic brain injuries.
Kyrsten Sinema unloaded $3 million of ...
Fitness guru Jillian Michaels discusses a Texas bill that funds research for the drug ibogaine on 'The Will Cain Show.